Pre-order Enquiry
Request Free Sample
Global Biologics Market Professional Survey Report 2019
SKU ID : QYR-14696759 | Publishing Date : 12-Sep-2019 | No. of pages : 114
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
The global Biologics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Biologics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biologics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Biologics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Biologics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
Segment by Application
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
The global Biologics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Biologics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biologics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Biologics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Biologics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
Segment by Application
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
